---
title: "Dian Diagnostics Group Co.,Ltd. (300244.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300244.SZ.md"
symbol: "300244.SZ"
name: "Dian Diagnostics Group Co.,Ltd."
industry: "Health Care Services"
datetime: "2026-05-20T22:34:11.847Z"
locales:
  - [en](https://longbridge.com/en/quote/300244.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300244.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300244.SZ.md)
---

# Dian Diagnostics Group Co.,Ltd. (300244.SZ)

## Company Overview

Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated pathology slide staining system, genotyping DNA test kit, human papillomavirus nucleic acid detection kit, PCR system and detection system, and virus collection and preservation system; and multi-omics platform services. It also provides DP-TOF nucleic acid mass spectrometry solutions, including mass spectroscopy system, automatic sample processing system, respiratory pathogens multiple detection kit, and nucleic acid sample pretreatment reagent kit; and forensic drug testing products comprises diangio, hair drug trace tester and detector, and saliva and urine drug testing product series.

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Exchange | CN Market |
| Website | [www.dazd.cn](https://www.dazd.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:11.000Z

**Overall: C (0.47)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 5 / 8 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -13.90% |  |
| Net Profit YoY | 132.24% |  |
| P/B Ratio | 1.82 |  |
| Dividend Ratio | 1.29% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 11876947984.30 |  |
| Revenue | 9995613988.81 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 1.98% | C |
| Profit Margin | 1.30% | C |
| Gross Margin | 29.47% | C |
| Revenue YoY | -13.90% | E |
| Net Profit YoY | 132.24% | A |
| Total Assets YoY | -7.44% | E |
| Net Assets YoY | -0.87% | D |
| Cash Flow Margin | 1571.33% | A |
| OCF YoY | -13.90% | E |
| Turnover | 0.68 | B |
| Gearing Ratio | 38.46% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Dian Diagnostics Group Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-13.90%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "132.24%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.82",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.29%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "11876947984.30",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "9995613988.81",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "1.98%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "1.30%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "29.47%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "-13.90%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "132.24%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-7.44%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-0.87%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "1571.33%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-13.90%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.68",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "38.46%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 89.33 | 4/8 | 101.98 | 94.11 | 91.50 |
| PB | 1.77 | 3/8 | 1.92 | 1.59 | 1.47 |
| PS (TTM) | 1.16 | 1/8 | 1.21 | 0.95 | 0.87 |
| Dividend Yield | 1.32% | 2/8 | 5.29% | 1.54% | 1.23% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | TC Medical (600763.SH) | B | C | C | B | C | B |
| 02 | HESH (301103.SZ) | C | C | C | A | B | B |
| 03 | Meinian Onehealth (002044.SZ) | C | D | C | C | B | C |
| 04 | Kingmed Diagnostics (603882.SH) | D | D | B | B | E | C |
| 05 | Dian Diagnostics (300244.SZ) | C | D | B | B | C | C |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-30T16:00:00.000Z

Total Analysts: **8**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 4 | 50% |
| Hold | 3 | 38% |
| Sell | 1 | 13% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 18.50 |
| Highest Target | 24.46 |
| Lowest Target | 8.50 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300244.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300244.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300244.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300244.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**